Rao B R, Fry C G, Hunt S, Kuhnel R, Dandliker W B
Cancer. 1980 Dec 15;46(12 Suppl):2902-6. doi: 10.1002/1097-0142(19801215)46:12+<2902::aid-cncr2820461432>3.0.co;2-o.
Fluorescein conjugates to estradiol-17 beta by the sixth carbon (6-FE) and to estrone by the 17th carbon (17-FE) were used to detect estrogen receptors (ERs) in breast cancer tissue sections and in cultured cell lines (human mammary carcinoma MCF-7 and Copenhagen rat prostatic tumor R3327-AT). 17-FE was found to interact with ERs better than 6-FE by biochemical and histochemical techniques. Thin layer chromatography analysis of ethanolic extracts of 17-FE incorporated in tissues and cultured cells showed that over 95% of 17-FE was not metabolized. We concluded that the fluorescence observed in tissue sections and cultured cells was due to 17-FE and not to fluorescein dissociated from the conjugate. Analysis of 65 human breast cancer showed that 74% of the cases were positive for specific 17-FE uptake and 26% were negative. The fluorescence was consistently brighter in the ductal and glandular epithelial cells than in the stroma. specific 17-FE uptake in the nucleoli was observed in MCF-7 and in R3327-AT tumor cells in in vitro cultures, suggesting that these nucleolar estrogen receptors may play a key role in the mechanism of estrogen action. Problems of fluorescence quantitation in tissue sections and cells are discussed.
通过第六个碳原子与雌二醇 - 17β结合的荧光素(6 - FE)以及通过第17个碳原子与雌酮结合的荧光素(17 - FE)被用于检测乳腺癌组织切片和培养细胞系(人乳腺癌MCF - 7和哥本哈根大鼠前列腺肿瘤R3327 - AT)中的雌激素受体(ERs)。通过生化和组织化学技术发现,17 - FE与ERs的相互作用比6 - FE更好。对掺入组织和培养细胞中的17 - FE乙醇提取物进行薄层色谱分析表明,超过95%的17 - FE未被代谢。我们得出结论,在组织切片和培养细胞中观察到的荧光是由于17 - FE,而不是从结合物中解离的荧光素。对65例人类乳腺癌的分析表明,74%的病例17 - FE特异性摄取呈阳性,26%呈阴性。导管和腺上皮细胞中的荧光始终比基质中的更亮。在体外培养的MCF - 7和R3327 - AT肿瘤细胞中观察到核仁中有特异性17 - FE摄取,这表明这些核仁雌激素受体可能在雌激素作用机制中起关键作用。文中讨论了组织切片和细胞中荧光定量的问题。